v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Operating activities:              
Net income $ 85,146 $ 69,737 $ 70,125 $ 88,905 $ 154,883 $ 159,030  
Adjustments to reconcile net income to net cash provided by operating activities:              
Depreciation and amortization         208,874 183,236  
Accretion of debt premium and discount, net         (1,379) (1,447)  
Deferred financing cost amortization         3,581 3,591  
Accretion of above- and below-market leases, net         (7,987) (4,894)  
Tenant inducement amortization and other         1,268 1,260  
Impairment of real estate assets         0 5,280  
Gain on sale of real estate assets         (18,825) (16,956)  
Equity based compensation         8,910 8,801  
(Gain) loss on extinguishment of debt, net         296 (281)  
Changes in operating assets and liabilities:              
Receivables, net         (1,771) 23,259  
Deferred charges and prepaid expenses         (20,779) (20,184)  
Other assets         146 (2,989)  
Accounts payable, accrued expenses and other liabilities         (15,675) (25,668)  
Net cash provided by operating activities         311,542 312,038  
Investing activities:              
Improvements to and investments in real estate assets         (171,333) (167,028)  
Acquisitions of real estate assets         (7,474) (17,470)  
Deposits on acquisitions of real estate assets         (15,000) 0  
Proceeds from sales of real estate assets         43,715 69,331  
Purchase of marketable securities         (5,574) (14,678)  
Proceeds from sale of marketable securities         6,686 12,751  
Net cash used in investing activities         (148,980) (117,094)  
Financing activities:              
Repayment of borrowings under unsecured revolving credit facility         (407,000) (98,500)  
Proceeds from borrowings under unsecured revolving credit facility         407,000 80,000  
Proceeds from unsecured notes         399,324 796,152  
Repayment of borrowings under unsecured notes         (632,312) (330,052)  
Deferred financing and debt extinguishment costs         (12,332) (7,315)  
Net proceeds from issuances of common shares         (143) 0  
Distributions to common stockholders         (177,711) (166,215)  
Repurchases of common shares in conjunction with equity award plans         (12,210) (12,962)  
Net cash provided by (used in) financing activities         (435,384) 261,108  
Net change in cash, cash equivalents and restricted cash         (272,822) 456,052  
Cash, cash equivalents and restricted cash at beginning of period   378,692   18,904 378,692 18,904 $ 18,904
Cash, cash equivalents and restricted cash at end of period 105,870   474,956   105,870 474,956 378,692
Reconciliation to consolidated balance sheets:              
Cash and cash equivalents 104,973   473,615   104,973 473,615 377,616
Restricted cash 897   1,341   897 1,341 1,076
Cash, cash equivalents and restricted cash at end of period 105,870   474,956   105,870 474,956 378,692
Supplemental disclosure of cash flow information:              
Cash paid for interest, net of amount capitalized of $2,223 and $1,927         110,573 84,793  
Change in accrued capital expenditures         (14,989) 2,278  
Brixmor Operating Partnership LP              
Operating activities:              
Net income 85,146 69,737 70,125 88,905 154,883 159,030  
Adjustments to reconcile net income to net cash provided by operating activities:              
Depreciation and amortization         208,874 183,236  
Accretion of debt premium and discount, net         (1,379) (1,447)  
Deferred financing cost amortization         3,581 3,591  
Accretion of above- and below-market leases, net         (7,987) (4,894)  
Tenant inducement amortization and other         1,268 1,260  
Impairment of real estate assets         0 5,280  
Gain on sale of real estate assets         (18,825) (16,956)  
Equity based compensation         8,910 8,801  
(Gain) loss on extinguishment of debt, net         296 (281)  
Changes in operating assets and liabilities:              
Receivables, net         (1,771) 23,259  
Deferred charges and prepaid expenses         (20,779) (20,184)  
Other assets         146 (2,989)  
Accounts payable, accrued expenses and other liabilities         (15,675) (25,668)  
Net cash provided by operating activities         311,542 312,038  
Investing activities:              
Improvements to and investments in real estate assets         (171,333) (167,028)  
Acquisitions of real estate assets         (7,474) (17,470)  
Deposits on acquisitions of real estate assets         (15,000) 0  
Proceeds from sales of real estate assets         43,715 69,331  
Purchase of marketable securities         (5,574) (14,678)  
Proceeds from sale of marketable securities         6,686 12,751  
Net cash used in investing activities         (148,980) (117,094)  
Financing activities:              
Repayment of borrowings under unsecured revolving credit facility         (407,000) (98,500)  
Repayment of secured debt obligations         0 0  
Proceeds from borrowings under unsecured revolving credit facility         407,000 80,000  
Proceeds from unsecured notes         399,324 796,152  
Repayment of borrowings under unsecured notes         (632,312) (330,052)  
Deferred financing and debt extinguishment costs         (12,332) (7,315)  
Net proceeds from issuances of common shares         (143) 0  
Partner distributions and repurchases of OP Units         (190,345) (179,772)  
Net cash provided by (used in) financing activities         (435,808) 260,513  
Net change in cash, cash equivalents and restricted cash         (273,246) 455,457  
Cash, cash equivalents and restricted cash at beginning of period   $ 378,032   $ 18,904 378,032 18,904 18,904
Cash, cash equivalents and restricted cash at end of period 104,786   474,361   104,786 474,361 378,032
Reconciliation to consolidated balance sheets:              
Cash and cash equivalents 103,889   473,020   103,889 473,020 376,956
Restricted cash 897   1,341   897 1,341 1,076
Cash, cash equivalents and restricted cash at end of period $ 104,786   $ 474,361   104,786 474,361 $ 378,032
Supplemental disclosure of cash flow information:              
Cash paid for interest, net of amount capitalized of $2,223 and $1,927         110,573 84,793  
Change in accrued capital expenditures         $ (14,989) $ 2,278